Body Composition of Infants: Follow-up to Placenta and Cord Blood Analyses

This study has been withdrawn prior to enrollment.
(determined not enough participants would be able to be enrolled and not enough data collected for good analyses)
Sponsor:
Information provided by (Responsible Party):
University of Arkansas
ClinicalTrials.gov Identifier:
NCT01464684
First received: October 31, 2011
Last updated: April 30, 2012
Last verified: April 2012
  Purpose

Investigators will characterize the body composition and metabolism of infants born from lean, overweight or obese mothers from whom they had previously obtained a placenta and/or cord blood as part of the earlier placenta and cord blood study (#111576)


Condition
Infant Body Composition and Metabolism

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Body Composition of Infants: Follow-up to Placenta and Cord Blood Analyses

Further study details as provided by University of Arkansas:

Biospecimen Retention:   Samples With DNA

Blood, urine, and a cheek swab may be collected from study participants


Enrollment: 0
Study Start Date: October 2011
Estimated Study Completion Date: December 2012
Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   3 Months to 21 Months
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

infants age 12 months (+/- 9 months)

Criteria

Inclusion Criteria:

  • mother's prior participation in study #111576 with successful collection of placenta
  • infant age 12 months (+/- 9 months)

Exclusion Criteria:

  • mother did not participate in study #111576
  • mother did participate in study #111576, but collection of placenta was not successful
  • infant not age 12 months (+/- 9 months)
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01464684

Sponsors and Collaborators
University of Arkansas
Investigators
Principal Investigator: Aline Andres, PhD University of Arkansas
  More Information

No publications provided

Responsible Party: University of Arkansas
ClinicalTrials.gov Identifier: NCT01464684     History of Changes
Other Study ID Numbers: 132624
Study First Received: October 31, 2011
Last Updated: April 30, 2012
Health Authority: United States: Food and Drug Administration

ClinicalTrials.gov processed this record on April 22, 2014